Table 2.
Adverse event | Rate of occurrence |
---|---|
Serious and/or life-threatening | (per million vaccinees) |
Death | 1–2 |
Postvaccinal Encephalitis | 3–9 |
Progressive Vaccinia | 1–7 |
Eczema Vaccinatum | 2–35 |
Moderate | (per million vaccinees) |
Generalized vaccinia | 40–200 |
Myopericarditis | 100 |
Accidental inoculation | 100–600 |
Bacterial Infection | Unknown |
Non-infectious rashes | 1–5% |
Mild (these are far more common, affecting 5–80% of vaccinees) | |
Itching | |
Fever | |
Lymphadenopathy | |
Headache | |
Nausea | |
Pain at vaccination site | |
Fatigue | |
Muscle aches | |
Chills |